You just read:

FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)

News provided by

Soligenix, Inc.

Jan 29, 2013, 07:00 ET